Filing Details
- Accession Number:
- 0001209191-22-035350
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-09 16:05:06
- Reporting Period:
- 2022-06-07
- Accepted Time:
- 2022-06-09 16:05:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1826892 | Bioatla Inc. | BCAB | Biological Products, (No Disgnostic Substances) (2836) | 851922320 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1835732 | Christian Vasquez | C/O Bioatla, Inc. 11085 Torreyana Road San Diego CA 92121 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-07 | 14,152 | $3.04 | 38,677 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-08 | 25,848 | $3.02 | 64,525 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-09 | 10,000 | $2.97 | 74,525 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The range of prices for the shares of Common Stock is from $2.66 to $3.10. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
- The range of prices for the shares of Common Stock is from $2.98 to $3.05. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
- The range of prices for the shares of Common Stock is from $2.93 to $3.00. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
Billionaire Hedge Funds
